Success Metrics

Clinical Success Rate

50.0%

Based on 3 completed trials

Completion Rate

50%(3/6)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Terminated

3(43%)

Phase Distribution

Ph not_applicable

71%

Ph phase_4

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 4Post-market surveillance

1(16.7%)

N/ANon-phased studies

5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(3)

Other(1)

Detailed Status

Completed3

Terminated3

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (16.7%)

N/A5 (83.3%)

Trials by Status

completed343%

terminated343%

unknown114%

Recent Activity

0 active trials

Showing 5 of 7

completednot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT04440579Not Applicable

Utilization of PTNS During Office-Based Cystoscopy

Completed

NCT03559946Not Applicable

Condensed Percutaneous Tibial Nerve Stimulation (PTNS) Protocol

Terminated

NCT04122703Not Applicable

Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction

Completed

NCT04451382

PTNS vs Botox of Refractory OAB

Terminated

NCT01162525Not Applicable

Percutaneous Tibial Nerve Stimulation for Patients With Fecal Incontinence

Completed

NCT02270190Not Applicable

PTNS as a Treatment for Tenesmus

Unknown

NCT01605617Phase 4

Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate

Terminated

All 7 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 7